Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on the Effects of Deucravacitinib for Patients with Moderate to Severe Plaque Psoriasis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany
  • Study on Long-term Safety and Effectiveness of Zasocitinib for Patients with Moderate-to-Severe Plaque Psoriasis

    Not recruiting

    3 1 1
    Investigated Drugs:
    Bulgaria Czechia France Germany Hungary Italy +3
  • Study on the Effects of IDP-122 Lotion for Children with Moderate to Severe Plaque Psoriasis

    Not recruiting

    2 1 1
    Investigated Drugs:
    Poland
  • Study on the Effectiveness and Safety of 0.1% Mometasone Furoate Emulsion and Ecural Cream for Adults with Plaque Psoriasis

    Not recruiting

    3 1 1
    Investigated Diseases:
    Poland
  • Study of deucravacitinib in adults with plaque psoriasis: Effects on immune system cells

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany
  • Study on the Effectiveness and Safety of Vibozilimod for Adults with Moderate to Severe Plaque Psoriasis

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Estonia Poland
  • Study on Long-Term Safety and Efficacy of Deucravacitinib for Patients with Moderate-to-Severe Plaque Psoriasis

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia Finland France Germany Hungary Poland +2
  • Study on the Safety, Effectiveness, and Blood Movement of Bimekizumab in Adolescents with Moderate to Severe Plaque Psoriasis

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Poland
  • Study on the Effects of JNJ-81241459 for Patients with Moderate to Severe Psoriasis

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Poland Spain
  • Study on Guselkumab for Patients with Moderate-to-Severe Plaque Psoriasis

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Germany